Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Vodafone tax saga (re)surfaces
Early last week, the Mumbai revenue department issued show cause notices to Vodafone, proposing to tax offshore transaction, as a result of which Vodafone acquired a controlling interest in GSM licences from Hutch.

Essar launches $150 mn rival bid for Australian coal firm
Ruias-led Essar Group has bid $150 million for taking over an Australian coal firm, Rocklands Richfields, bettering an earlier offer from Jindal Steel and Power.

News of the day

Zenotech Labs June qtr net loss widens to Rs 3.41 cr
Drug maker Zenotech Laboratories today said reported Rs 3.41 crore loss for the quarter ended June 30, against a net loss of Rs 2.66 crore in the same period previous fiscal.
Small Business

Strides Arcolab, Pfizer in pact to sell drugs in US

Strides Arcolab announced a collaboration with Pfizer, USA on Thursday where Pfizer will commercialise the later"s off-patent sterile injectables and oral products in the US. - Strides Arcolab soars on Pfizer deal - Pfizer to source 40 off-patent cancer care drugs from Strides - TCG Life signs pact with Pfizer - Dr Reddy"s plans to launch Lipitor"s generic version in US - Strides Arcolab ends court process for merger - SEC probes 9 deals for insider-trading violations These finished dosage form products will be licensed and supplied by Strides and two South Africa-based JVs of Strides where Strides holds 50%. Pfizer will commercialise around 40 off-patent products in the oncology area. The first product will be launched this year.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009